Novolimus™
Novolimus™ is an active metabolite of Sirolimus. NOVOLIMUS™ is developed by Elixira Medical Corp.
It is a mTOR inhibitor macrocyclic lactone with anti-proliferative and anti-inflammatory properties.
Novolimus™ is an active metabolite of Sirolimus. NOVOLIMUS™ is developed by Elixira Medical Corp.
It is a mTOR inhibitor macrocyclic lactone with anti-proliferative and anti-inflammatory properties.